Menu Search
Equities

Ihuman Inc

IH:NYQ

Ihuman Inc

Actions
TechnologyTechnology
  • Price (USD)1.59
  • Today's Change0.000 / 0.00%
  • Shares traded3.00
  • 1 Year change-45.40%
  • Beta0.4078
Data delayed at least 15 minutes, as of Sep 20 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Ihuman Inc grew revenues 3.31% from 985.52m to 1.02bn while net income improved 64.73% from 109.82m to 180.91m.
Gross margin70.84%
Net profit margin17.77%
Operating margin15.70%
Return on assets13.00%
Return on equity20.95%
Return on investment20.89%
More ▼

Cash flow in CNYView more

In 2023, Ihuman Inc increased its cash reserves by 15.60%, or 163.77m. The company earned 172.12m from its operations for a Cash Flow Margin of 16.91%. In addition the company used 6.51m on investing activities and also paid 9.45m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share2.57
Tangible book value per share2.51
More ▼

Balance sheet in CNYView more

Ihuman Inc appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio2.82
Quick ratio2.78
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.